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Chapter 4 
WHO expert committees and key concepts for drugs, alcohol, and tobacco, 1949–
2013 
Suzanne Taylor, Virginia Berridge, and Alex Mold 
4.1 Introduction to the WHO expert committees and key concepts for drugs, alcohol, and 
tobacco 
While other historical chapters of this book have studied national and regional situations, 
this chapter provides an international perspective by examining the role of the World 
Health Organization (WHO) and its expert committees in disseminating concepts around 
addiction in relation to illicit drugs, alcohol, and tobacco from 1949 to 2013. Three time 
periods are surveyed: 1949–1963, when intense discussion of concepts and terminology in 
relation to drugs and alcohol occurred and the substances were discussed as separate 
issues; 1964–1989, when the concept of dependence emerged, ushering in the potential for 
a combined approach to the substances, and also when discussion of tobacco arose; and the 
1990s onwards, when a more sustained combined approach to the substances developed 
and the WHO exercised its constitutional powers to establish an international convention 
on tobacco. Major questions considered in this chapter include:  
 What were the concepts discussed in relation to illicit drugs, alcohol, and tobacco?  
 What terms were used and how were they defined? 
 What were the similarities and differences in terminology across the substances?  
 How were the expert committees situated within the WHO, and where did 
responsibility lie for each substance? 
 What was the impact of the professional composition of committees? 
 How did the terminology used in expert committee reports compare to that of the 
International Classification of Diseases (ICD), the standard diagnostic tool for 
epidemiology? 
 How did the terminology used in expert committee reports compare to that used in 
conventions and for health management and clinical purposes? 
Review of the WHO expert committees demonstrates considerable engagement with 
concepts and terminology, and the importance of the WHO in establishing and shifting the 
conceptual boundaries between these substances. It highlights increasing linkages between 
the three substances under consideration; a more combined approach to research and 
treatment, but differences in control; early involvement with the problems of substance use 
and earlier discussion of tobacco than has generally been indicated in the existing 
literature; and the problems involved in the creation of standardized definitions at the 
international level. Box 4.1 provides a list of acronyms pertinent to this chapter. 
Box 4.1 Key acronyms used in relation to the WHO expert committees and key concepts for 
drugs, alcohol, and tobacco, 1949–2013 
ADS: Alcohol-Dependence Syndrome 
ARD: Alcohol-Related Disability  
ECAPD: Expert Committee on Addiction-Producing Drugs  
ECDD: Expert Committee on Drug Dependence  
ECDLPA: Expert Committee on Drugs Liable to Produce Addiction  
ECDPD: Expert Committee on Dependence-Producing Drugs  
FCTC: Framework Convention on Tobacco Control 
ICD: International Classification of Diseases 
PSA: Programme on Substance Abuse 
SACTob: Scientific Advisory Committee on Tobacco Product Regulation  
TFI: Tobacco Free Initiative  
TobReg: WHO Study Group on Tobacco Product Regulation  
UN: United Nations 
WHA: World Health Assembly 
WHO: World Health Organization 
 
4.2 Historiography: role of the WHO, expert committees, and concepts and terminology 
around addiction in relation to drugs, alcohol, and tobacco  
A literature review was carried out on secondary material on the WHO and illicit drugs, 
alcohol, and tobacco. This included topics on the history of the WHO, the development of 
international control mechanisms, WHO expert committees, and other relevant 
mechanisms such as the ICD and UN Conventions. Much literature on the WHO has 
concentrated on its role in combatting infectious diseases. Health promotion and public 
health has also been discussed; since the 1970s there has been interest in international 
substance control, both illicit drugs and alcohol. The mechanism of the expert committee 
has been examined demonstrating its importance in the development of concepts, 
terminology, and definitions. Bruun et al. (1975) examined expert committees on drugs 
and alcohol and highlighted their significance in the development of key concepts; the 
importance of a committee’s composition, policy imperatives, and outputs. Room (1981) 
has written extensively on this topic, focusing on alcohol and drugs. His analysis 
demonstrated the fluctuating focus of committees and major turning points, such as the 
1992 ECDD (Room, 1997). Room uncovered significant shifts in terminology; for example, 
the transition from ‘habit’ and ‘addiction’ to ‘dependence’, and from ‘alcoholism’ to ‘alcohol-
related problems’ (Room, 2005; Room & Babor, 2005; Selvaggio, 1984). He also considered 
the development of alcohol and drug categories in instruments such as the ICD, revealing 
its relationship with the WHO, problems of cross-cultural applicability of terms such as 
‘dependence’, differentials between lay and technical understandings, and cross-drug 
applicability of terms (Room, 1984, 1997, 1998).  
Edwards (2007), reviewing the WHO’s 1977 report on alcohol-related disabilities, 
highlighted the lack of commonly accepted terminology as an obstacle to research and 
policy. His work emphasized the shift to ‘disability’ as the preferred term to describe the 
social burden resulting from disease. The changes in the WHO structure—for example, the 
Programme on Substance Abuse (PSA) which sought to bring a combined approach to 
substance abuse in the 1990s—has also attracted commentary (Babor, 2003; Grant, 1993). 
Work has largely considered these substances separately.  
Tobacco has not been considered in relation to drugs and alcohol. Little has been said 
about expert committee discussion of tobacco despite its inclusion in WHO discussions 
from 1970. The Framework Convention on Tobacco Control (FCTC) in 2005 is noteworthy. 
Taylor and Bettcher (2000) analyzed the development of international health law. Collin et 
al. (2002) discussed the FCTC in the context of accelerating globalization. Civil society 
contributions to the negotiation process proved important for tobacco (Mamudu & Glant, 
2009); Yach and Bettcher (2000) demonstrated that the tobacco industry increasingly 
attempted to influence agencies such as the WHO. Likewise Weishaar et al. (2012) have 
pointed to the transnational tobacco corporations’ efforts to undermine the FCTC. The 
applicability of the framework to other substances has been the focus of a number of works 
(Jernigan et al., 2000; Lien & Deland, 2011; Room & Babor, 2005). A final aspect of the 
literature is that it is generally written by non-historians, many employed or connected to 
the WHO. Although this has the advantage of insider knowledge, it tends to lack context and 
to be allied to an activist perspective (Moser, 1980; Yach & Monteiro, 2011; see also the 
conversations with Mackay, 2013; Moser, 1984; and Room, 2012).  
The existing literature has demonstrated the importance of expert committees, but it has 
largely reviewed the substances individually and tends to concentrate on drugs and alcohol, 
not tobacco. Tobacco has been studied but with a greater focus on the development of the 
FCTC rather than its longer history at the WHO. As noted, the literature has largely been 
written by those with connections to the WHO rather than by historians. In this chapter we 
consider the three substances together under the umbrella of ‘concepts of addiction’. We 
examine the relationship between concepts and terminology across these three substances, 
and extend their consideration from the involvement of the WHO in 1949 through 2013.  
4.3 Methodology: the WHO expert committees, Technical Report Series, and WHO archives 
As well as the literature review summarized earlier, the research examined printed reports 
and archival material. Examination of original printed material focused upon the Technical 
Report Series, which published findings of the expert committees; reports on illicit drugs, 
alcohol, and tobacco were reviewed. Other primary material included WHO Conventions, 
texts of which were surveyed for pertinent terms. Terms used in the ICD in relation to 
drugs, alcohol, and tobacco were reviewed. Although rarely utilized, we surveyed material 
held in the WHO archives in Geneva. Unfortunately, the archive does not hold minutes of 
meetings, but it does hold other relevant documentation, such as correspondence between 
committee members.  
4.4 WHO expert committees on illicit drugs and alcohol, and the early development of 
terminology, 1949–1963 
WHO expert committees are the highest official advisory bodies to the Director-General of 
WHO and member states. They are established by the WHO World Health Assembly (WHA) 
and each committee makes recommendations on a subject of interest to the WHO. 
Members are chosen from WHO expert advisory panels, temporary advisers, 
representatives from international organizations, nongovernmental organizations, and 
professional associations. The ECDD has been one of the most active committees, meeting 
every two years since it was established in 1949 (undergoing various title alterations). It 
has played a central role in the international drug control system, making 
recommendations to the United Nations Commission on Narcotic Drugs on control 
measures. In contrast, alcohol and tobacco committees, not needing to make scheduling 
decisions in relation to international conventions, have met less frequently, often in 
response to a WHA resolution calling for research on a particular area of emerging interest.  
This chapter splits the expert committee discussions into three time periods: 1949–1963, 
when intense discussion of concepts and terminology in relation to drugs and alcohol 
occurred, and the substances were discussed as separate issues; 1964–1989, when the 
concept of ‘dependence’ emerged and ushered in the potential for a combined approach to 
the substances, and when discussion of tobacco arose; and the 1990s onwards, when a 
more sustained combined approach to the substances developed, and the WHO exercised 
its constitutional powers to establish an international convention on tobacco. Drug 
committees were more active than alcohol and tobacco committees. Between 1949 and 
1963, terminology was a crucial factor in discussions (see Table 4.1). In relation to illicit 
drugs, the main term used was ‘habit-forming’; the first committee established in 1949 was 
named the Expert Committee on Habit-Forming Drugs. Members were 
pharmacologists/chemists, and discussions centred on the status of various substances in 
relation to the conventions on controlled drugs (WHO, 1949).  
Please insert Table. 4.1 here.  
But attention turned to a new term—‘addiction’—and in 1950 the committee renamed the 
Expert Committee on Drugs Liable to Produce Addiction (ECDLPA). Attempts were made to 
differentiate between the two terms. A ‘habit-forming’ drug was described as ‘one which is, 
or may be, taken repeatedly without the production of all of the characteristics outlined in 
the definition of addiction and which is not generally considered to be detrimental to the 
individual and to society.’ The term referred mainly to ‘psychic dependence’, whereas ‘drug 
addiction’—which implied both ‘psychic’ and ‘physical’ dependence—was preferred by the 
committee. Addiction was defined as ‘a state of periodic or chronic intoxication, 
detrimental to the individual and the society, produced by the repeated consumption of a 
drug (natural or synthetic) . . . a psychic (psychological) and sometimes a physical 
dependence on the effects of the drug’. ‘Dependence,’ a term that would become prominent 
in the 1960s, was mentioned but not defined. The committee decided that ‘habit-forming’ 
should be eliminated from all texts, and urged governments to consider medical research 
on ‘drug addiction’.  
The distinction between the two was important because attempts were made to link these 
concepts to control measures. A 1952 committee acknowledged that the term ‘addiction’ 
implied a serious state, one which ‘must be rigidly controlled.’ In contrast, drugs resulting 
in ‘habituation’ were thought more innocuous, as they ‘cause no sociological damage and 
do not need rigid control’ (WHO, 1952a). This split proved problematic because some 
‘borderline’ drugs such as alcohol fell into an intermediate position and were outside 
international control.  
Discussion of alcohol focused more on the condition of ‘alcoholism’, taking a more medical 
approach. The first expert committee, the WHO Expert Committee on Mental Health’s 
Alcoholism Subcommittee of 1951, focused on conceptual discussion of ‘alcoholism’ (WHO, 
1951). Its membership mainly psychiatrists, it was chaired by Dr G.A.R. Lundquist, 
assistant professor of psychiatry at Langbro Hospital, Stockholm. The secretariat included 
Prof. E.M. Jellinek, a WHO consultant on alcohol and dean of the Yale Institute of Alcohol 
Studies; much of the historical literature has focused on his work on alcoholism. The 
subcommittee made clear that ‘alcoholism’ was a disease and a social problem in which 
public health services should play a significant role in prevention and treatment.  
Terminology occupied a large part of the committee’s report. The initial term used was 
‘chronic alcoholism’, but this was quickly discredited due to cross-cultural 
misunderstandings—an important consideration for the WHO working in a global 
environment. ‘Alcoholism’, defined as ‘any form of drinking which in its extent goes beyond 
the traditional and customary dietary use or the ordinary compliance with social drinking 
customs,’ was seen to have a more consistent meaning and became the preferred term. 
‘Alcoholism’ was refined into stages which were important because of their clinical 
significance and potential treatment regimes. In referring to ‘addictive drinking’, the 
subcommittee noted the work of the 1950 Expert Committee on Drugs Liable to Produce 
Addiction (ECDLPA) on definitions for ‘addiction’. The subcommittee acknowledged 
similarities to drugs of addiction, but maintained a distinction in that it was ‘uncertain 
whether or not the pharmacological concomitants of drug addiction exist . . . creating a 
physical dependence on the drug.’ This led to pressure for a new subcommittee under the 
ECDLPA to examine the potential ‘drug of addiction’, alcohol, rather than the ‘disease’ of 
‘alcoholism’.  
The Subcommittee on Alcoholism met again in 1951. Chaired by Dr M. Schmidt, chief 
psychiatrist, Department of Police, Denmark, it concentrated on practical and specific 
aspects of ‘alcoholism’. The previous subcommittee’s provisional definition of ‘alcoholism’ 
was adopted for ‘excessive drinkers’, while alcoholics were defined as  
<EXT>excessive drinkers whose dependence upon alcohol . . . shows a noticeable mental 
disturbance or an interference with their bodily and mental health, their inter-personal 
relations and their smooth social and economic functions. . . . They therefore require 
treatment. (WHO, 1952b)</EXT>   
The position of alcohol in relation to other drugs became increasingly important, especially 
as the term ‘addiction’ became dominant in relation to illicit drugs. An Expert Committee 
on Alcohol was created and reported in 1954 (WHO, 1954). The composition of the alcohol 
committee differed from that of the previous committees on ‘alcoholism’; it comprised 
mainly pharmacologists and physiologists (later committees also had a wider range of 
disciplines). The committee was chaired by Dr Lundsgaard, professor of physiology at the 
University of Copenhagen, and included professors of pharmacology such as Dr L. Goldberg 
from Stockholm and Dr J. Mardones from Santiago, Chile, an associate professor of 
medicine from Stanford University, and L.D. MacLeod from the Burden Neurological 
Institute, Bristol. They discussed broader ramifications—etiological, epidemiological, 
sociological, and anthropological—as opposed to purely pharmacological or clinical 
concerns. 
The committee drew on the work of the 1950 ECDLPA, which added to the confusion, 
because alcohol and ‘alcoholism’ could not easily be fitted into the definition of ‘drug 
addiction’. Alcohol was placed in a category of its own, one intermediate between 
‘addiction-producing’ and ‘habit-forming’. Concepts pertaining to the pharmacological 
position of alcohol remained unclear; for instance, the term ‘tolerance to alcohol’ was seen 
as causing misunderstandings. A distinction was deemed necessary between ‘tolerance’ 
related to addiction-producing drugs of the morphine type and ‘tolerance’ associated with 
alcohol. ‘Withdrawal symptoms’ also proved contentious, as in the alcohol field, the term 
‘withdrawal symptoms’ was used, whereas the term ‘abstinence syndrome’ was used in the 
case of drug addiction of the morphine type. Thus the committee was unable to match the 
definitions between alcohol and illicit drug terminology. The separate category for alcohol 
was necessitated by the difficulty of drawing a line between the presence and absence of 
addiction-producing properties (WHO, 1954). The subcommittee pressed for a further 
meeting incorporating both clinicians and experimental workers to attempt further 
clarification.  
This borderline position of alcohol remained important for the Expert Committee on 
Alcohol and Alcoholism which met in 1955 (WHO, 1955). Jellinek and Wolff had left; a 
changing membership drew together pharmacologists, physiologists, psychiatrists, and 
members from both  the Mental Health and the ECDLPA. Its mandate was to clarify basic 
concepts related to alcohol and the features of the problem in different countries. The 
committee reiterated the importance of ‘alcoholism’ as a medical problem in order to 
involve public health services. However, this was proving difficult due to inadequately 
defined terminology.  
The introduction of the concept of ‘problems of alcohol’ or ‘problem use’ forced a broader 
consideration of the problem. This shift away from ‘alcoholism’ was important because it 
was ‘excessive drinking’ rather than ‘alcoholism’ which was a major problem for most 
countries. One approach was to cease using the term ‘craving’ and adopt ‘physical 
dependence’. Though the 1955 committee acknowledged recent evidence which indicated a 
closer resemblance between responses to the withdrawal of alcohol and opiates, it 
concluded that there was no justification for a change in the position on alcohol. Instead, 
the preferred concept became the ‘problems of alcohol’, of which ‘alcoholism’ was just one 
aspect.  
‘Addiction’ continued to pose problems for illicit drugs, and the renamed Expert Committee 
on Addiction-Producing Drugs (ECAPD) revisited the issue (WHO, 1957). Its membership 
began to broaden. Significantly, the committee included Dr L. Goldberg, who sat on the 
1954 Expert Committee on Alcohol, and for the first time included a psychiatrist, Dr 
Pernambuco Filho, University of Rio, Brazil. The distinction between ‘addiction’ and ‘habit-
forming’ remained problematic. The committee was forced to refine the previous 
definitions, as follows: 
<EXT>Drug addiction: Its characteristics include: (1) an overpowering desire or need or 
compulsion to continue to take the drug; . . . (2) a tendency to increase the dose; (3) a 
psychic (psychological) and generally a physical dependence on the effects of the drug; (4) 
detrimental effects on the individual and on society.  
Drug habitation (habit): (1) a desire (but not a compulsion) to continue taking the drug for 
the sense of improved well-being which it engenders; (2) little or no tendency to increase 
the dose; (3) some degree of psychic dependence on the effect of the drug but absence of 
physical dependence and hence of an abstinence.</EXT> 
These new definitions were to find some acceptance by the time of the 1960 committee but 
they were far from perfect. The committee complained that heterogeneous criteria had 
been included to meet the requirements of international control, but this made definitions 
difficult to interpret. Hence they reiterated the basis of control, which was related to risk to 
the community: the ‘fundamental criterion for control is the extent to which these drugs 
induce behaviour disturbance and risk to the community’ (WHO, 1960).   
A significant shift appeared when interest expanded to the user and the methods of 
prevention and treatment as opposed to the pharmacological action of drugs. The issue of 
the ‘addict’ and ‘treatment’ appeared in the 1958 expert committee report (WHO, 1958) 
after pressure by the UN Economic and Social Council. It became significant as the 
committee pressed for an opportunity to comment on drafts of the 1961 UN Single 
Convention on Narcotic Drugs. The convention enshrined the term ‘addiction’, a term the 
expert committees would later try to replace. In 1959 the committee had raised disquiet 
over the schedules for the convention, the scope of control, and the treatment of drug 
addicts (WHO, 1959). Attitudes towards drug addicts and their treatment came to the fore 
in 1961 when the committee discussed the medical control of addicts. Though proposals 
for civil commitment of an addict (in the case of mental patients) to a medical panel were 
approved, they were not deemed a replacement for legal penalties (WHO, 1961). The 1962 
committee pointed out that although ‘withdrawal’ must be the first step in treatment, for a 
‘cure’ to be successful, ‘rehabilitation’ was necessary, and hence there was an immediate 
need for treatment and rehabilitation facilities.  
In sum, during this period both drug and alcohol committees were active. Tobacco was not 
considered at this point. Drugs and alcohol were considered by separate committees, but 
concepts and terms were important areas of discussion for both committees. Drug 
committees initially were made up mostly of pharmacologists, but later were slightly 
widened to include other disciplines, notably the occasional inclusion of a psychiatrist and 
one member who had also sat on the alcohol committee. This period saw a shift from the 
term ‘habit-forming’ to ‘addiction’, though the term remained problematic. Drug 
committees had been established to provide advice in relation to pre-existing international 
drug control treaties, so the focus was on the substance, though there was a slight shift to 
consider the problems of use—for example, consideration of the ‘addict’ by the end of this 
period. 
In contrast, there were no international treaties for alcohol control. Hence the WHO began 
with health concerns over the condition, not the ‘drug’. Committees on alcoholism began as 
largely psychiatric-based and focused on the condition ‘chronic drinking’ and later 
‘alcoholism’. Later committees, which included pharmacologists, physiologists, and 
psychiatrists, considered ‘alcohol’ and the ‘problems of alcohol use’ and ‘excessive drinking’ 
rather than just ‘alcoholism’. Although some similarities were drawn with illicit drugs, 
significantly, alcohol was deemed to occupy an intermediate position. Furthermore, in 
contrast with drug committees, alcohol committees began with an interest in prevention 
and rehabilitation and an acknowledgement of the significance of cultural differences in 
alcohol use.  
4.5 The rise of ‘dependence’, tobacco, and the prevention of problems associated with 
substance use, 1964–1989 
During the period 1964–1989, the concept of ‘dependence’ developed and opened the way 
for a combined approach to the substances. Though the 1971 UN Psychotropic Drugs 
Convention led to a focus on scheduling requirements rather than drug terminology and 
interest in alcohol declined by the 1980s, some influential reports emerged. These reports 
emphasized the concept of a medical rather than a penal approach, the threat to the 
community as well as the individual, and the need for prevention of both drug and alcohol 
‘related problems’ rather than a narrow focus on supply. Additionally, during this period 
tobacco entered the WHO’s consciousness as a serious global public health threat (Table 
4.2). 
Please insert Table 4.2 here 
A significant moment was the adoption of the term ‘dependence’ by the 1964 ECAPD, 
chaired by Dr N.B. Eddy, a pharmacologist and consultant on narcotics, National Institutes 
of Health, USA. The committee consisted largely of pharmacologists but did include one 
psychiatrist, Dr P. Kielholz, University of Basel, Switzerland. Moreover, the committee had a 
different emphasis: it welcomed the fact that other agencies, such as the Commission on 
Narcotic Drugs, were pushing for an increased emphasis on the sociological and economic 
aspects of ‘drug abuse’. With the increasing number of drugs available and continuing 
confusion over ‘addiction’ and ‘habituation’, it had proved difficult to find a term that could 
be applied generally to ‘drug abuse’. The concept of ‘dependence’ was seen as a common 
factor between the many varieties of drugs. Though the term had been loosely used 
previously, it became the preferred term, defined as 
<EXT>a state arising from repeated administration of a drug on a periodic or continuous 
basis. Its characteristics will vary with the agent involved and this must be made clear by 
designating a particular type of drug dependence in each specific case. (WHO, 1964) p9, 
</EXT> 
Specific types of drug dependence were elucidated; for example, drug dependence of the 
morphine type. Crucially, ‘dependence’ was not linked to any type of control. The 1965 
committee was renamed the Expert Committee on Dependence-Producing Drugs (ECDPD) 
(WHO, 1965).  
But ‘dependence’ had flaws. Criticisms were made of the vagueness of the term, cross-
cultural applicability, and cross-drug applicability. Furthermore, it created conflicts with 
the ICD. The section which covered drug addiction in the ICD contained a diverse list of 
terms, which the committee argued were not necessarily addiction-producing drugs in a 
pharmacological or legal sense. The report therefore recommended that ‘drug dependence’ 
be taken into account by the ICD.  
There was added pressure for clarity when the committee’s mandate was broadened in 
1966 and again in 1969: from the determination of the control status of drugs to other 
aspects of ‘drug dependence’ and ‘abuse’ (WHO, 1969). The committee’s name was also 
altered to Expert Committee on Drug Dependence (ECDD) in 1969. In addition to 
pharmacologists, membership of the ECDD was widened to include Dr A. Wikler, professor 
of psychiatry and pharmacology, University of Kentucky, and Dr P.H. Connell, a psychiatrist 
at the Bethlem and Maudsley Hospital, London. This shifting membership resulted in a shift 
towards the condition rather than a strict focus on the drug. ‘Drug abuse’ was defined as 
‘persistent or sporadic excessive drug use inconsistent with . . . acceptable medical practice.’ 
‘Drug abuse’ was deemed convenient on the grounds that there was no universally 
accepted term. By 1975 the term ‘abuse’ would be dropped by the WHO due to its 
stigmatizing connotations (Kramer & Cameron, 1975), though it remained in the ICD until 
1992. 
These developments meant that the split between alcohol and illicit drugs was harder to 
sustain. The WHO wanted to encourage authorities to look at ‘alcohol and alcoholism and 
use and abuse of drugs together’. Although a more combined approach had been sought by 
the Expert Committee on Mental Health, this was more in relation to research (and to a 
lesser extent with treatment and education), as opposed to control measures (WHO, 
1967b). 
The increasingly combined approach to drugs and alcohol was reflected in the 1967 Expert 
Committee on Mental Health Services for the Prevention and Treatment of Dependence on 
Alcohol and Other Drugs (WHO, 1967a). This committee was chaired by Dr K. Evang, 
Director-General, Health Services of Norway, and consisted of sociologists, psychiatrists, 
neuropsychiatrists, and a pharmacologist. It also included representatives from the UN 
narcotic drug organizations, such as Mr A. Lande, secretary to the Permanent Central 
Narcotics Board, as well as those from the alcohol field, including Mr H.D. Archibald, 
director of the Alcoholism and Drug Addiction Research Foundation, Toronto, Canada. The 
broader disciplinary backgrounds reflected the committee’s mandate, which was to 
consider the establishment of services for the prevention and treatment of ‘dependence’ on 
both alcohol and other drugs. 
The rationale to combine the approaches was persuasive. The concept of ‘dependence’ 
brought the concepts around the differing substances closer together. The committee noted 
the similarities in causation and treatment, and the fact that drugs were themselves often 
used in combination. Research from the alcoholism field was also viewed as relevant to 
controlled drugs, and it was accepted that, although attitudes towards ‘alcoholism’ had 
shifted towards the therapeutic, this had not happened to the same extent with controlled 
drugs.  
Tobacco, when it surfaced as an issue for the WHO, did so within a different framework: 
public health. A 1970 report of the Director-General, based on the work of Charles Fletcher 
and Daniel Horn (1970), leading anti-smoking campaigners, sought to establish the 
problem as worthy of consideration by the WHO by referring to the links to diseases such 
as lung cancer, as well as the increasing uptake of smoking, especially by women. The 
report led the WHO to affirm the hazards of smoking and to ban smoking in its own 
meetings. The concept of ‘less hazardous smoking’ arose, alluding to the development of 
‘less hazardous’ cigarettes and methods of smoking. Other methods such as filters were 
also considered, and the report called for research on the effects on health of modifications 
in the constituents of cigarettes. A follow-up report in 1971 focused on potential methods 
of control (WHO, 1971). Legislation was considered important; for example, in enacting 
measures to encourage smokers to stop. The ‘less hazardous cigarette’ remained an option 
and differential taxation favouring the use of ‘less harmful cigarettes’ was discussed. Any 
economic losses from reduced tobacco revenue were expected to be offset by a healthier 
population. By the early 1970s, tobacco would enter discussions of the drug committees.  
But the major focus of the early 1970s was psychotropic drugs, culminating in the UN 
Convention on Psychotropic Substances in 1971. Psychotropic drugs had become a priority 
for the committee in 1970, when draft protocols of the convention were sent to the ECDD. 
At this time the committee consisted mainly of pharmacologists, although there were two 
psychiatrists, one of whom was Dr M. Shepherd, Institute of Psychiatry, London. The 
convention necessitated refinement of the terminology. A link to ‘dependence’ was one 
criterion for control. The term ‘psychotropic’ applied only to substances specifically listed 
in one of the first four schedules; the committee accepted that many psychotropic 
substances used in medicine did not produce ‘dependence’. Therefore, to avoid confusion, a 
qualifying term, ‘dependence-producing’, was introduced to be added when speaking of 
psychotropic substances to be controlled in the draft protocol. This committee also 
broached the concept of a medical rather than penal approach, emphasizing treatment and 
rehabilitation within public health services.  
The 1973 committee reflected the rise of the public health population approach; it 
consisted of a wider range of disciplines, with epidemiologists and sociologists joining the 
pharmacologists and psychiatrists. This led to further refinements around the concept of 
‘dependence’ with a focus upon ‘dependence-producing drugs and more interest in the 
problems surrounding the use of such drugs’ (WHO, 1973). ‘Dependence’ in itself was not 
necessarily considered harmful—in a broad sense, it could include tea and coffee—
whereas drugs, such as alcohol, cannabis, and opiates, resulted in individual, public health, 
and social problems. 
Thus by 1974 there was a shift in focus to prevention of the problems associated with drug 
use. The committee was chaired by Dr B.S. Brown, Director of the National Institute of 
Mental Health, Department of Health, Education, and Welfare, USA, and included several 
members of the UN Division on Narcotic Drugs, including Dr O.J. Braenden, and members of 
the International Council on Alcohol and Addiction. Dr H. Halbach, a professor of 
pharmacology at the University of Munich, was invited to consider what was known about 
preventing problems associated with the use of psychoactive, dependence-producing drugs. 
This shift meant that alcohol gained a higher profile because it was deemed more of a 
problem than many illicit drugs. Tobacco—the most widespread form of drug 
dependence—was also drawn into discussion. However, tobacco was excluded from pre-
review (the preliminary stage to decide whether a substance should undergo a fully 
documented or critical review which might lead to the scheduling of a psychoactive 
substance) on the grounds that its psychotoxic effects were slight compared to other drugs 
(WHO, 1974).  
Yet tobacco warranted its own expert committee (WHO, 1970). Following a 1974 
resolution requesting that an expert group be convened, the Expert Committee on Smoking 
and its Effects on Health was created. It met in 1975 to summarize evidence on the harmful 
effects of smoking and to propose actions to discourage smoking. Hence, tobacco was 
isolated from committees concerned with illicit drugs; smoking entered the expert 
committee’s realm from a public health perspective. This was reflected in its membership, 
which was mainly social medicine and public health experts, cardiologists, and 
policymakers (WHO, 1975b). It was chaired by Sir George Godber, the UK Chief Medical 
Officer, with Dr Sujoy B. Roy, professor and head of Department of Cardiology at the All-
India Institute of Medical Sciences, New Delhi, acting as the rapporteur. Its members 
included Dr F. Beske, professor of social medicine and public health, Secretary of State, 
Ministry of Social Affairs, Kiel, Germany. Charles Fletcher acted as a temporary adviser. 
This committee reviewed the state of knowledge since Fletcher and Horn’s 1970 report and 
reviewed the gamut of potential control measures, including warning notices, prohibition 
in certain public places, and protection of the rights of ‘non-smokers’, as well as quality 
control and education. Some terms used were similar to those adopted for alcohol and 
drugs, including ‘psychic dependence’ and ‘withdrawal’. Although drug terminology had 
moved away from ‘habit’ or ‘habitation’ early on, the phrase ‘smoking habit’ was widely 
used in reports. Few terms were defined. In relation to nicotine, the term ‘dependence’ was 
adopted: ‘Chronic use of nicotine produce dependence and . . . or some people the 
disturbing nicotine withdrawal syndrome . . . contributes to the difficulty of giving up.’ Thus 
the issue of ‘withdrawal’, developed in drug and alcohol committees, was picked up for 
tobacco, but differences were also identified: social reinforcement and ‘dependence’ were 
thought to develop faster with tobacco than with other drugs such as alcohol.  
At the same time, the effects of smoking were accepted as extending beyond the individual 
user. What would become known later as ‘passive smoking’ was discussed as ‘involuntary 
exposure to smoke.’ The report noted potential damage to non-smokers: ‘the non-smoker 
exposed to the side stream and mainstream of smokers in enclosed, ill-ventilated spaces 
such as cars and small offices may be exposed to harmful concentrations of smoke.’ This 
threat to the wider community boosted the need for stricter control measures. 
Furthermore, by protecting the non-smoker it was hoped to reduce opportunities for 
smoking.  
Threat to the wider community was an important concept for all these substances. This 
was especially true with alcohol. As discussed by Room (1984), work during this time 
focused on alcohol’s impact on the community beyond the individual drinker. The question 
of ‘alcohol disabilities’ was discussed by a WHO Steering Group between 1973 and 1975, 
resulting in a broader focus than the ‘alcoholic’. ‘Alcohol-related disabilities’ and later 
‘alcohol-related problems’ became the focus at the WHO. The emphasis on ‘disability’ 
rather than disease was intended to draw attention to the need to reduce the consequences 
on the family and society, as well as the individual. Although concrete definitions were not 
deemed possible, a loose definition was the following:  
<EXT>Alcohol-Related Disability is deemed to exist when there is impairment in the 
physical, mental or social functioning of an individual of some nature that it may be 
reasonably inferred that it is part of the causal nexus determining that disability. (Edwards 
et al., 1977)</EXT> 
By 1976 ‘dependence’ was adopted by the alcohol field. Alcohol-dependence syndrome was 
seen as one variety of alcohol-related disability (ARD) and was adopted by the 1980 
committee. Not all those with ARD were seen as alcohol-dependent but were at more risk 
of becoming so. ‘Alcohol dependence’ entered the ninth revision of the ICD.  
Whereas with alcohol attempts were made to ‘manage’ associated problems, with tobacco 
the goal was elimination. Tighter control of the smoking epidemic was the primary focus of 
the 1979 tobacco expert committee. Membership was weighted to anti-smoking advocates. 
The committee was chaired by Sir George Godber, with Dr Nigel Grey, of the Anti-Cancer 
Council of Victoria, Australia, as rapporteur. Others included Dr K. Bjartveit, Chairman of 
the National Council on Smoking and Health, Oslo, and Dr L. Ramstrom, Director-General of 
the National Smoking and Health Association, Stockholm. Significantly, the aim was 
elimination, ‘removal of the hazard not marginal reduction’ (WHO, 1979). This meant that 
the concept of the ‘safe cigarette’ was rejected. Instead, potential methods of control 
leading to elimination were promoted, including control of advertising , health warnings, 
taxation, restrictions on smoking in public places, and evaluation of legislation. Crucially, 
this report marked the first calls for the use of WHO’s constitutional powers to develop an 
international treaty.  
To summarize, although the 1971 Psychotropic Convention came into force during this 
period and there was less discussion of concepts around illicit drugs as the committees 
became more involved in technical discussion over scheduling, there were significant 
developments. There were major changes to the drug committees’ composition, with 
pharmacologists being joined by epidemiologists, sociologists, and those working in the 
alcohol field. There was also a shift in how the problems were conceptualized. ‘Addiction’ 
was replaced by ‘dependence’ and ‘dependence-producing drugs’, a move which brought 
potential for a more combined approach to the substances. As such, alcohol became an 
issue as it could be seen as a ‘dependence-producing drug’. 
Another important change was a shift in interest to not just the prevention of drug use but 
the limitation of problems once drug use had occurred. There were limited reports on 
alcohol, but, significantly, concepts developed around ‘alcohol-related disabilities’ and 
‘alcohol-related harm’. Importantly, smoking emerged as a public health problem and 
warranted the establishment of its own expert committee. Membership of the committee 
was broad both in geographical location and disciplines but with a medical/public health 
emphasis. The focus was on the elimination of smoking, though the idea of the ‘less 
hazardous cigarette’ emerged, and calls began for WHO to exercise its constitutional 
powers for an international legal approach to tobacco control.  
4.6 A combined approach? the Programme on Substance Abuse and the Framework 
Convention on Tobacco Control, 1990–2013  
The period from 1990 to 2013 is characterized by a more sustained combined approach to 
substance use. This was reflected in changes to the WHO structure, with the creation of the 
Division of Mental Health and the Prevention of Substance Abuse’s Programme on 
Substance Abuse (PSA). This period is also marked by the development of global strategies 
for tobacco control, most notably the Framework Convention on Tobacco Control, which 
represented the first time the WHO had exercised its constitutional powers (Table 4.3).  
Please insert Table 4.3 here 
Mounting pressure for a combined approach to drugs and alcohol was built into the 
structure of the WHO in the 1990s. The WHO’s global strategy of ‘health for all by the year 
2000’ led in 1990 to the creation of a new programme, the PSA, designed to prevent and 
control alcohol and drug abuse. This resulted in alcohol and drugs being briefly separated 
from the mental health division. Expert committees began to review the substances 
together. The Expert Committee on Health Promotion in the Workplace reviewed 
approaches to health promotion as a means of preventing both alcohol and drug problems. 
Alcohol and drug-related problems were defined as being applicable to any of the adverse 
accompaniments of drinking or drug-taking, and they could be related to either an 
individual drinker or to society (WHO, 1993b).  
The 1993 ECDD also considered alcohol, and—although it was initially outside of the PSA’s 
remit—tobacco was also included in discussions. Membership was broad, including 
psychopharmocologists, addiction psychiatrists, epidemiologists, and policymakers. The 
director-general of the WHO had requested the committee look at strategies for reducing 
substance use and its harmful consequences. Crucially, the tenth edition of the ICD (ICD-10) 
included alcohol and tobacco in the list of psychoactive drugs with potential to cause 
mental and behavioural disorders, including ‘dependence’. The committee discussed the 
concept of drawing together illicit and licit substances and coordinating their control 
mechanisms. In terms of tobacco, the committee argued that the ‘dependence-producing’ 
properties of nicotine and the severe health consequence of tobacco and nicotine 
warranted its inclusion in their discussions, thereby further expanding the committee’s 
mandate.  
In redefining the role of the committee, concepts and terminology occupied an important 
place. Many of the terms from the previous reports remained valid, but with new research 
findings there were important subtle shifts. ‘Harmful use’—‘a pattern of psychoactive drug 
use that causes damage to health, either mental or physical. . . . Harmful use of drugs by an 
individual often has adverse effects on the drug user’s family, the community and society’—
replaced the term ‘abuse’, which was deemed ambiguous (WHO, 1993a, p. 6). However, it 
was recognized that the term ‘drug abuse’ had entered numerous national laws and 
international conventions, so ‘abuse’ remained in operation.  
‘Dependence’ remained dominant. The committee decided to follow the ICD-10 diagnostic 
guidelines and not make a distinction between ‘physical dependence’ and ‘psychic 
dependence’ in order to avoid clinical misunderstandings (WHO, 1993a, p. 5). However, 
there was a shift towards ‘problems’ or ‘disabilities related to drug use’, of which 
‘dependence’ was just one. Further review of the term ‘dependence-producing drug’ drew 
nicotine and tobacco into consideration. The level of dosage of a drug now also came into 
prominence: ‘A state of dependence is not necessarily harmful in itself, but it may lead to 
self-administration of the drug at dosage levels that produce deleterious physical or 
behavioural changes constituting public health and social problems’ (WHO, 1993a, p. 6). 
Research had led to a reconceptualization of alcohol consumption levels as a continuum 
and to an understanding that alcohol-related problems were related to consumption 
patterns. This was now seen as applicable to all substances, resulting in a change in focus 
on those with ‘less heavy patterns of use’ (WHO, 1993a, p. 4). Thus concepts and 
terminology around levels of consumption were becoming important.  
Discussion of ‘harm minimization’, ‘harm reduction’, or the ‘preventing of problems 
associated with the use of psychoactive dependence-producing drugs’ now explicitly 
appeared in texts; the committee highlighted the value of harm reduction as opposed to the 
potential of psychoactive drugs for encouraging drug use (WHO, 1993a, p. 3).  
Common approaches were brought together when another reorganization took place in 
1995. At that time the Programme on Substance Abuse was amalgamated with the Division 
of Mental Health to create the Division of Mental Health and Prevention of Substance Abuse 
(WHO, 1997). Significantly, this division was involved with all psychoactive substances, licit 
or illicit, including tobacco, alcohol, and illicit drugs.  
The 1995 ECDD reflected these changes, acknowledging that although different legal 
approaches existed for drugs, alcohol, and tobacco, there were significant similarities in 
treatment options. Consequently, the committee sought treatments that could be used 
across the three substances. Treatment and rehabilitation were meant to include 
‘comprehensive identification, assistance, healthcare, and social integration.’ Consistent 
with growing interest in ‘human rights’ in relation to controlled drugs, inherent in the 
definition was the idea that all users should be treated ‘with humanity and respect’ (WHO, 
1995a).  
In 2000, the Department of Substance Abuse was merged with the Department of Mental 
Health to create the Department of Mental Health and Substance Abuse, under the Non-
Communicable Disease and Mental Health cluster, thus bringing together common 
approaches to the management of mental health and substance use disorders.  
Amendments were seen as essential given the adverse attitudes towards drug users; the 
committee pressed for an update to the WHO (1994) Lexicon of Alcohol and Drug Terms, a 
tool for clinicians, administrators, and researchers, which had been established .  
Tobacco had proved awkward for the ECDD. Although approaches to research and 
treatment had drawn substances closer together, approaches to control took a different 
track. The existing conventions were not deemed appropriate for regulating tobacco, 
because the only option would be prohibition, which was not viable. The idea of an 
alternative global mechanism for tobacco control was formalized in 1995 at the World 
Health Assembly (WHO, 1995b). By 1997 the PSA had a section specifically for tobacco—
Tobacco or Health—and the development of an international framework was an important 
element of its strategy. It published Guidelines for Controlling and Monitoring the Tobacco 
Epidemic, advocating long-term, comprehensive tobacco control policies (WHO, 1998).  
In 1998, after Gro Harlem Brundtland, a physician herself, became director-general of the 
WHO, tobacco control activities were set within a new structure. The Tobacco Free 
Initiative (TFI), run by Dr Derek Yach, aimed to raise the profile of tobacco control. Its role 
was to initiate a process to develop a framework convention that would permit member 
states to adopt a comprehensive tobacco control policy dealing with aspects of tobacco 
control that transcended national boundaries. While tobacco had been rejected for pre-
review in 1996 by the ECDD, by 1999 this decision was reversed because of new evidence 
of greater liability for abuse (WHO, 1999a). In 2000, the WHO Framework Convention on 
Tobacco Control (FCTC) was adopted by the WHA, becoming the first international treaty 
negotiated under the auspices of the WHO (2003b); it came into force in 2005.  
Terms such as ‘addiction’, ‘nicotine addiction’, ‘addictive nature’, and ‘tobacco dependence’ 
and ‘cessation’, were used but they were not defined in the treaty. ‘Habit’, while frequently 
adopted in discussions, did not appear in the treaty text. Definitions related more to the 
needs of the treaty, and so were focused more on issues of control, trade, and products than 
on usage. The definition of tobacco control included supply, demand, and ‘harm reduction’ 
strategies. ‘Harm reduction’ itself was not defined; the emphasis remained on elimination. 
Engagement with definitions emerged via a new body. The Scientific Advisory Committee 
on Tobacco Product Regulation (SACTob) was established in 2000 with the objective to 
advise WHO on the most effective, evidence-based means to fill regulatory gaps in tobacco 
control and thus achieve a coordinated regulatory framework. In 2003 this advisory 
committee was formulized into a study group, and it became known as the WHO Study 
Group on Tobacco Product Regulation (TobReg). Its report of 2006–2008 considered 
product regulation, including cigarette contents. ‘Dependence’ was used as a synonym for 
‘addiction’; beginning in 2012, the term ‘addiction’ was dropped. Reflecting a focus on the 
consumer, the term ‘attractiveness’ crept in, a phrase that did not appear for drugs or 
alcohol. Reports noted that cigarettes were exempt from health and safety standards; the 
aim of the WHO FCTC was to lay the ground for future regulation of contents. Whereas the 
concept of a ‘safe cigarette’ had earlier been rejected, ‘harm-reduction’ methods were again 
a feature. A detailed explanation of ‘harm reduction’ based on other organizations’ 
definitions was provided, but the study group pointed out that any such action ‘must not 
undermine prevention, cessation and reduction of exposure to second-hand smoke and, 
ideally, should support them’ (WHO, 2007b).  
The approach to alcohol followed that taken for tobacco rather than for ‘illicit’ drugs. The 
coordinated global public health approach became a feature of alcohol policy, which 
focused on reducing the problems of consumption. In 2001, Gro Harlem Brundtland spoke 
publicly on alcohol issues for the first time, and a WHO Alcohol Policy Strategic Advisory 
Committee was established. A WHO resolution in 2005 called for evidence-based strategies 
to reduce alcohol-related harm (WHO, 2005). The 2007 WHO Expert Committee on 
Problems Related to Alcohol Consumption pressed the WHO to develop a global action plan 
to reduce the harmful effects of consumption. The committee argued for clear definitions of 
alcohol-related terms, particularly in the area of policy. 
Definitions reflected this altered focus; for example ‘alcohol-related harm’ and ‘problems 
related to alcohol consumption’ were seen as equivalent terms encompassing a wide 
variety of health and social problems at the individual and societal level (WHO, 2007a). 
Although ‘harmful use’ was in the ICD-10, the WHO expert committee argued for a broader 
understanding, one related to the public health aims of the WHO, in which the ‘risk of harm’ 
now appeared as a part of ‘alcohol-related harm’. Distinctions, however, were drawn, and 
problems with the term ‘harm reduction’ in relation to alcohol noted (WHO, 2007a).  
At the same time, the term ‘intoxication’ was introduced. Intoxication was defined as ‘a 
predictable consequence of the ingestion of substantial quantities of alcoholic beverages in 
a limited period of time.’ Although ‘intoxication’ was part of the ICD, the committee pointed 
out a number of factors that affected it, including cultural differences and the amount 
consumed. Intoxication was seen as leading to ‘risk taking behaviours’ such as unprotected 
sexual activity, which could lead to ‘disabilities’ and impose burdens on health services and 
third parties.  
‘Dependence’ was again accepted with respect to alcohol. Significantly, the committee 
noted that if alcohol had been considered under the 1971 convention, it would have 
qualified for scheduling, as it constituted a public health and social problem (WHO, 2007a). 
However, as with tobacco, it was not considered practical to include alcohol in current 
conventions. Instead, by 2008 the WHO had drafted a global strategy which included 
national actions, such as policies for drunk driving, while at the international level priority 
areas included public health advocacy and partnership, as well as the production and 
dissemination of knowledge (WHO, 2010).  
In sum, this period is characterized by a more sustained combined approach to substance 
use and its related problems. With drugs, in particular, prevention of drug use–related 
problems—of which ‘dependence’ was just one aspect—became important. In so doing, 
concepts of ‘harm reduction/minimization’ entered discussions. Common approaches, 
especially for treatment and rehabilitation, were examined, but differences in control 
policy remained. This is highlighted by the major development in the tobacco field with 
creation of the FCTC. Alcohol policy was reinvigorated with a focus on ‘alcohol-related 
harm’ and pressure for a global policy in light of developments in tobacco control.  
4.7 Conclusion: the development and role of the WHO expert committees in ‘concepts of 
addiction’ for drugs, alcohol, and tobacco 
This review of the WHO expert committees on illicit drugs, alcohol, and tobacco reveals 
attempts at the difficult task of standardization of terms around ‘concepts of addiction’, the 
development of an increasingly combined approach to these substances, moves to bring 
tobacco and alcohol into a public health agenda over which the WHO has control, and 
attempts to influence the illicit drug agenda.  
WHO expert committees were very active in changing concepts and definitions around 
‘addiction’. The term ‘habit-forming’, and its replacement, ‘addiction,’ quickly proved 
unsatisfactory, especially in light of their links to control measures, as well as ‘borderline’ 
substances which could not be defined by either term. ‘Addiction’ was replaced by the 
concept of ‘dependence’ and a focus on ‘dependence-producing drugs’. 
The shift to ‘dependence’ highlighted similarities between illicit and licit substances. For 
example, alcohol became an issue, as it could be seen as a ‘dependence-producing drug’. 
This opened the door to a more combined approach to the substances, at least in relation to 
research and treatment, although less so for control. A major change was a shift in interest 
not only to prevention of substance use but the limitation of problems or ‘disabilities’ once 
such use had occurred. Further refinement led to concepts around levels of consumption; 
for example, an increasing concern with ‘excessive drinking’ rather than a focus on 
‘alcoholism’. 
A term that appeared in discussions for all these substances—although it proved 
contentious—was ‘harm reduction’. This was interesting in the case of tobacco, for which 
there was emphasis on the concept of ‘elimination’. However, even though elimination was 
impractical, concern remained for those unwilling or unable to quit; thus the concept of 
‘harm reduction’ had to be considered. The balance between ‘harm reduction’ and 
‘elimination’ proved difficult, as evidenced by the issue of ‘less hazardous’ or ‘safer’ 
cigarettes. Recently, it has led to much debate over e-cigarettes. Finally, although tobacco 
discussions largely drew on terms already established for alcohol and drugs, they also 
brought new terms such as ‘consumer attractiveness’ into the discussion.  
Changing scientific disciplines within the committee system have played an important role 
in the development of concepts and terms. Early drug committees dominated by 
pharmacologists focused on the substance, whereas alcohol committees, initially 
dominated by psychiatrists, concentrated on the medical condition. Broadening the 
professional disciplinary base to include pharmacologists, psychiatrists, sociologists, and 
clinicians, and cross-fertilization between the committees, led to greater interest in 
treatment and rehabilitation and eventually in combined approaches. In contrast, tobacco 
committees had a medical/public health composition and focus from the start.  
The organizational structure of the  WHO has also been important. Alcohol and drugs were 
both placed under mental health but were initially considered by separate committees. 
Increasingly, however, linkages brought research and potential treatment options closer 
together. Nevertheless, approaches to control have differed. Control was a given for illicit 
drugs, with international mechanisms and conventions established within a penal 
framework developed prior to the creation of the WHO. But this was not the case for 
alcohol and tobacco. Alcohol committees increasingly sought to emphasize the medical 
aspects of the problem to ensure a public health–oriented approach. In contrast, tobacco, 
seen as an epidemic, even pandemic, entered WHO’s consciousness as a public health issue, 
and one with added impetus due to the threat to the non-smoker. Tobacco’s position in 
relation to the other substances is interesting. Initially considered separately, it was later 
incorporated into the PSA. Later still it began to follow its own track, leading to the 
formation of the FCTC whereby the WHO set the precedent for a convention under its own 
auspices. Alcohol became the only one of the three substances without some form of 
international control mechanism. WHO began to press for alcohol to be dealt with as a 
global public health issue and drew inspiration from the tobacco convention.  
WHO committees did not operate in isolation. Differences existed between committees, 
conventions, diagnostic tools, and common usage of terms. In addition, there were time 
lags between committee discussions and changes to diagnostic mechanisms such as the ICD. 
For example, the WHO committees pressed the ICD to include ‘dependence’. The 
committees might also be at odds with other organizations such as the American 
Psychiatric Association, which wanted to reinstate ‘addiction’ in the 2006 edition of its 
Diagnostic and Statistical Manual. While the ICD-11 has retained ‘dependence’, the 
psychiatric association proposed to replace it with ‘substance use disorder’.  
Finally, terminology is not fixed. Rather, it is in constant flux, due to changing scientific 
understanding, evolving drugs, and new delivery methods. Ever-changing policy 
imperatives, cultural differences, and attempting to meet the needs of different actors 
contribute to the mix. Thus the debates are ongoing around dosage, ‘intoxication’, and 
levels of use. The current debate concerning ‘heavy use over time’ as a replacement for the 
concepts discussed in relation to addiction (Rehm, 2013) suggests that the WHO and its 
expert committees will continue to play an important role. 
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Table 4.1 Major WHO expert committee reports, 1949–1963  
Date  Committee Output Substance 
Major shifts 
in 
terminology 
1949 Expert Committee 
on Habit-Forming 
Drugs 
[First report]  Drugs Habit-
forming; 
habituation 
1950 Expert Committee 
on Drugs Liable to 
Produce Addiction 
Second report Drugs Addiction  
1951 Expert Committee 
on Mental Health 
Alcoholism 
Subcommittee  
First report Alcohol Alcoholism; 
chronic 
alcoholism; 
addictive 
drinking 
1952a Expert Committee 
on Drugs Liable to 
Produce Addiction 
Third report  Drugs   
1952b Expert Committee 
on Mental Health 
Alcoholism 
Subcommittee  
Second report Alcohol Alcoholism; 
excessive 
drinkers 
1954a Expert Committee 
on Alcohol 
First report  Alcohol Alcohol 
intermediate 
between 
habit-
forming and 
addiction-
producing 
     
     
1955a Expert Committee 
on Alcohol and 
Alcoholism 
‘Alcohol and 
Alcoholism: 
Report of an 
Expert 
Committee’ 
Alcohol Excessive 
drinking 
rather than 
alcoholism; 
problems of 
alcohol use 
or problem 
use, of which 
alcoholism 
is one aspect 
1956 Expert Committee 
on Drugs Liable to 
Produce Addiction 
Sixth report [of a 
meeting held in 
Geneva, 24–29 
October 1955] 
Drugs   
1957 Expert Committee 
on Addiction-
Producing Drugs 
Seventh report Drugs Addiction-
producing 
drugs 
1958 Expert Committee 
on Addiction-
Producing Drugs 
Eighth report Drugs Interest in 
treatment 
for the 
‘addict’  
1959 Expert Committee 
on Addiction-
Producing Drugs 
Ninth report  Drugs   
1960 Expert Committee 
on Addiction-
Producing Drugs 
Tenth report Drugs   
1961 Expert Committee 
on Addiction-
Producing Drugs 
Eleventh report Drugs Medical 
control of 
addicts 
1961 Convention UN Single 
Convention on 
Narcotic Drugs 
Drugs   
      
 
 
Table 4.2 Major WHO expert committees reports, 1964–1989 
Date  Committee Output Substance 
Major shifts in 
terminology 
1964 Expert 
Committee on 
Addiction-
Producing Drugs 
Twelfth report  Drugs Dependence; drug 
abuse 
1965 Expert 
Committee on 
Dependence-
Producing Drugs 
Fourteenth 
report  
Drugs Dependence-
producing drugs 
1966 Expert 
Committee on 
Dependence-
Producing Drugs 
Fifteenth 
report  
Drugs   
1967 Expert 
Committee on 
Mental Health 
Fourteenth 
report [of a 
meeting held in 
Geneva, 4–10 
October 1966]  
Alcohol and 
drugs 
  
      
1969 Expert 
Committee on 
Drug 
Dependence 
Sixteenth 
report  
Drugs   
      
1970 Expert 
Committee on 
Drug 
Dependence 
Eighteenth 
report  
Drugs  Psychotropic 
drugs and the 
qualifying term 
‘dependence-
producing’ 
1970   C.M. Fletcher 
and D. Horn, 
‘Smoking and 
Health’  
Tobacco Less hazardous 
smoking/cigarette 
      
1973  Expert 
Committee on 
Drug 
Dependence 
Nineteenth 
report  
Drugs   
1974  Expert 
Committee on 
Drug 
Dependence  
Twentieth 
report  
Drugs, alcohol, 
and tobacco 
Problems 
associated with 
the use of 
psychoactive, 
dependence-
producing drugs; 
includes alcohol 
and tobacco but 
tobacco excluded 
from pre-review 
1975  Expert 
Committee \ on 
Smoking and its 
Effects on Health 
Smoking  and 
its Effets on 
Health 
Meeting: 
Report 
Tobacco Psychic 
dependence and 
withdrawal; 
smoking habit; 
dependence 
adopted in 
relation to 
nicotine; 
involuntary 
exposure to 
smoke 
     
      
1979 Expert 
Committee on 
Smoking Control 
‘Controlling the 
Smoking 
Epidemic’ 
Tobacco Elimination; 
rejection of the 
safe cigarette 
     
1980 Expert 
Committee on 
Problems 
Related to 
Alcohol 
Consumption. 
Meeting 
(1979) in 
Geneva  
Alcohol Alcohol-related 
disabilities; 
alcohol 
dependence 
syndrome 
Problems related 
to alcohol 
consumption 
1983 Expert 
Committee, 
Smoking Control 
Strategies in 
Developing 
Countries 
Report  Tobacco   
1985 Expert 
Committee on 
Drug 
Dependence 
Twenty-second 
report  
Drugs   
1987 Expert 
Committee on 
Drug 
Dependence 
Twenty-third 
report  
Drugs   
1988 Expert 
Committee on 
Drug 
Dependence 
Twenty-fourth 
report 
Drugs   
1989 Expert 
Committee on 
Drug 
Dependence 
Twenty-fifth 
report  
Drugs   
1989 Expert 
Committee on 
Drug 
Dependence  
Twenty-sixth 
report  
Drugs   
Table 4.3 Major WHO expert committee reports, 1990–2013 
Date Committee Output Substance 
Major shifts in 
terminology/focus  
1991 Expert 
Committee on 
Drug 
Dependence Twenty-
seventh report  
Drugs   
1993a Expert 
Committee on 
Drug 
Dependence 
Twenty-eighth 
report  
Drugs Harmful use to 
replace abuse; 
dependence; 
disabilities or 
problems related 
to drug use of 
which 
‘dependence’ was 
just one factor; 
alcohol 
consumption and 
levels of use; e.g. 
less heavy 
patterns of use; 
harm 
minimization 
1993b Expert 
Committee on 
Health 
Promotion in the 
Workplace 
‘Alcohol and 
Drug Abuse’  
Drugs and 
Alcohol 
  
1995a Expert 
Committee on 
Drug 
Dependence 
Twenty-ninth 
report 
Drugs Different legal 
approaches to 
control but 
similarities of 
treatment options 
for drugs, alcohol, 
and tobacco  
  
 
  
1999a Expert 
Committee on 
Drug 
Dependence 
Thirty-first 
report  
Drugs Tobacco included 
for pre-review  
2000 Expert 
Committee on 
Drug 
Dependence   
Drugs   
     
2001 Expert 
Committee on 
Drug 
Dependence  
 Thirty-second 
report   
    
2003a Expert 
Committee on 
Drug 
Dependence 
Thirty-third 
report  
Drugs   
     
2006 Expert 
Committee on 
Drug 
Dependence 
Thirty-fourth 
report 
  
Drugs   
2006 Study Group on 
Tobacco Product 
Regulation 
Meeting in 
Kobe, Japan, 
28–30 June 
 
Scientific basis 
of tobacco 
product 
regulation  
Tobacco Attractiveness; 
harm reduction; 
dependence used 
as a synonym for 
addiction 
2006 Expert 
Committee on 
Problems 
Related to 
Alcohol 
Consumption  
[First report]  Alcohol   
2007a Expert 
Committee on 
Problems 
Related to 
Alcohol 
Consumption 
Second report  Alcohol Alcohol-related 
harm; problems 
related to alcohol 
consumption; risk 
of harm; 
intoxication 
 
  
  
